Alpha-1 antitrypsin therapy in new-onset type 1 diabetes: interim results from Part I of the RETAIN study

被引：0
|
作者：
Ehlers, M. R. [1 ]
Gottlieb, P. A. [2 ]
Herold, K. [3 ]
Rigby, M. R. [4 ]
Willi, S. M. [5 ]
Aggarwal, S. [6 ]
Phippard, D. [6 ]
Gelmont, D. M.
Jepson, B. [7 ]
McNamara, J. [8 ]
Strom, T. [9 ]
Weir, G. C. [10 ]
机构：
[1] Immune Tolerance Network, Clin Trials Grp, San Francisco, CA USA
[2] Barbara Davis Ctr, Aurora, CO USA
[3] Yale Univ, New Haven, CT USA
[4] Indiana Univ, Indianapolis, IN 46204 USA
[5] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA
[6] Immune Tolerance Network, Bethesda, MD USA
[7] RhoFed Inc, Biostat, Chapel Hill, NC USA
[8] NIAID, DAIT, Bethesda, MD 20892 USA
[9] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
[10] Joslin Diabet Ctr, Boston, MA 02215 USA
来源：
DIABETOLOGIA | 2012年 / 55卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
147
引用
收藏
页码：S67 / S67
页数：1
相关论文
共 50 条
  • [1] Alpha-1 antitrypsin treatment of new-onset type 1 diabetes: An open-label, phase I clinical trial (RETAIN) to assess safety and pharmacokinetics
    Weir, Gordon C.
    Ehlers, Mario R.
    Harris, Kristina M.
    Kanaparthi, Sai
    Long, Alice
    Phippard, Deborah
    Weiner, Lia J.
    Jepson, Brett
    McNamara, James G.
    Koulmanda, Maria
    Strom, Terry B.
    PEDIATRIC DIABETES, 2018, 19 (05) : 945 - 954
  • [2] Alpha-1 Antitrypsin Therapy in Recent-Onset Type 1 Diabetes
    Lebenthal, Yael
    Brener, Avivit
    Hershkovitz, Eli
    Shehadeh, Naim
    Shalitin, Shlomit
    Gai-Castro, Sharon
    Stein, Michal
    Tov, Naveh
    Rachmiel, Marianna
    DIABETES, 2018, 67
  • [3] Metabolic and immunologic observations from a trial of alpha-1 antitrypsin in recent onset type 1 diabetes
    Gottlieb, P.
    Michels, A.
    Di Domenico, D.
    Fitzgerald-Miller, L.
    Johnson, K.
    Lungaro, J.
    Meyers, L.
    Conley, A.
    Zipris, D.
    DIABETOLOGIA, 2012, 55 : S193 - S193
  • [4] ALPHA-1 ANTITRYPSIN OVEREXPRESSING MESENCHYMAL STROMAL CELLS PREVENTS ONSET OF TYPE 1 DIABETES
    Wei, H.
    Gou, W.
    Lotfy, A.
    Green, E.
    Strange, C.
    Wang, H.
    CYTOTHERAPY, 2023, 25 (06) : S98 - S98
  • [5] Alpha-1 antitrypsin therapy is safe and well tolerated in children and adolescents with recent onset type 1 diabetes mellitus
    Rachmiel, Marianna
    Strauss, Pnina
    Dror, Nitzan
    Benzaquen, Hadassa
    Horesh, Orit
    Tov, Nave
    Weintrob, Naomi
    Landau, Zohar
    Ben-Ami, Michal
    Haim, Alon
    Phillip, Moshe
    Bistritzer, Tzvi
    Lewis, Eli C.
    Lebenthal, Yael
    PEDIATRIC DIABETES, 2016, 17 (05) : 351 - 359
  • [6] Alpha 1 Antitrypsin (AAT) deficiency and new-onset diabetes in a pediatric patient
    Mahmood, F.
    Battle, S.
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2024, 367 : S266 - S267
  • [7] Control of inflammation with alpha1-antitrypsin: A potential treatment for islet transplantation and new-onset type 1 diabetes
    Weir, Gordon C.
    Koulamnda, Maria
    CURRENT DIABETES REPORTS, 2009, 9 (02) : 100 - 102
  • [8] Control of inflammation with alpha1-antitrypsin: A potential treatment for islet transplantation and new-onset type 1 diabetes
    Gordon C. Weir
    Maria Koulamnda
    Current Diabetes Reports, 2009, 9 : 100 - 102
  • [9] Therapeutic Potential of Alpha-1 Antitrypsin in Type 1 and Type 2 Diabetes Mellitus
    Park, Sangmi S.
    Ortega, Romy Rodriguez
    Agudelo, Christina W.
    Perez, Jessica Perez
    Gandara, Brais Perez
    Garcia-Arcos, Itsaso
    McCarthy, Cormac
    Geraghty, Patrick
    MEDICINA-LITHUANIA, 2021, 57 (04):
  • [10] Alpha-1 antitrypsin deficiency: A study from the registry
    Khoor, A
    HUMAN PATHOLOGY, 2004, 35 (12) : 1433 - 1434
12345